Cargando…
Genotyping Cancer-Associated Genes in Chordoma Identifies Mutations in Oncogenes and Areas of Chromosomal Loss Involving CDKN2A, PTEN, and SMARCB1
The molecular mechanisms underlying chordoma pathogenesis are unknown. We therefore sought to identify novel mutations to better understand chordoma biology and to potentially identify therapeutic targets. Given the relatively high costs of whole genome sequencing, we performed a focused genetic ana...
Autores principales: | Choy, Edwin, MacConaill, Laura E., Cote, Gregory M., Le, Long P., Shen, Jacson K., Nielsen, Gunnlaugur P., Iafrate, Anthony J., Garraway, Levi A., Hornicek, Francis J., Duan, Zhenfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077728/ https://www.ncbi.nlm.nih.gov/pubmed/24983247 http://dx.doi.org/10.1371/journal.pone.0101283 |
Ejemplares similares
-
Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma
por: Feng, Yong, et al.
Publicado: (2015) -
MicroRNA-155 expression is independently predictive of outcome in chordoma
por: Osaka, Eiji, et al.
Publicado: (2015) -
Recurrent Chromosomal Copy Number Alterations in Sporadic
Chordomas
por: Le, Long Phi, et al.
Publicado: (2011) -
Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11
por: Liao, Yunfei, et al.
Publicado: (2017) -
Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11
por: Liao, Yunfei, et al.
Publicado: (2018)